Natural Product: NPC2771| Natural Product ID | NPC2771 |
|
Common Name
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
| 4'-Methoxyflavone |
| IUPAC Name | 2-(4-methoxyphenyl)chromen-4-one |
| Synonyms | 4'-Methoxyflavone; 4-Methoxy Flavone |
| Synthetic Gene Cluster | n.a. |
| ChEMBL Identifier | CHEMBL16312 |
| PubChem CID |
77793 |
| Chemical Classification |
|
The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.
Chemical Representations
| Standard InCHIKey | OMICQBVLCVRFGN-UHFFFAOYSA-N |
| Standard InCHI | InChI=1S/C16H12O3/c1-18-12-8-6-11(7-9-12)16-10-14(17)13-4-2-3-5-15(13)19-16/h2-10H,1H3 |
| SMILES | COc1ccc(cc1)c1cc(=O)c2c(o1)cccc2 |
  Calculated Properties
  Species Source| Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
|---|---|---|---|---|---|---|---|---|
| NPO28809 | Cullen corylifolium | Species | Fabaceae | Eukaryota | n.a. | fruit | n.a. |
PMID[20663508] |
| NPO28809 | Cullen corylifolium | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[24507928] |
| NPO28809 | Cullen corylifolium | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[9544566] |
| NPO28809 | Cullen corylifolium | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[COCONUT] |
| NPO28809 | Cullen corylifolium | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO28809 | Cullen corylifolium | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
| NPO28809 | Cullen corylifolium | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  NP Quantity Composition/Concentration| Organism ID | Organism Name | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
|---|
Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Biological Activity
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT261 | Individual protein | Monoamine oxidase A | Homo sapiens | Inhibition | = | 40.0 | % | PMID[20045650] |
| NPT149 | Individual protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 1000.0 | nM | PubChem BioAssay data set |
| NPT151 | Individual protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 14125.4 | nM | PubChem BioAssay data set |
| NPT109 | Individual protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 1995.3 | nM | PubChem BioAssay data set |
| NPT154 | Individual protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | n.a. | 11220.2 | nM | PubChem BioAssay data set |
| NPT157 | Individual protein | Breast cancer type 1 susceptibility protein | Homo sapiens | Potency | n.a. | 19952.6 | nM | PubChem BioAssay data set |
| NPT152 | Individual protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 8912.5 | nM | PubChem BioAssay data set |
| NPT1602 | Individual protein | Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | IC50 | = | 8740.0 | nM | PMID[31744778] |
| NPT582 | Individual protein | Monoamine oxidase B | Homo sapiens | IC50 | = | 27870.0 | nM | PMID[20045650] |
| NPT483 | Individual protein | Prelamin-A/C | Homo sapiens | Potency | = | 11220.2 | nM | PubChem BioAssay data set |
| NPT537 | Individual protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 1995.3 | nM | PubChem BioAssay data set |
| NPT501 | Individual protein | Alpha-galactosidase A | Homo sapiens | Potency | = | 44668.4 | nM | PubChem BioAssay data set |
| NPT585 | Individual protein | Nuclear receptor subfamily 0 group B member 1 | Homo sapiens | IC50 | > | 67535.0 | nM | PubChem BioAssay data set |
| NPT501 | Individual protein | Alpha-galactosidase A | Homo sapiens | Potency | n.a. | 12589.3 | nM | PubChem BioAssay data set |
| NPT72 | Individual protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 105.58 | % | PMID[23571415] |
| NPT48 | Individual protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
| NPT48 | Individual protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 3981.1 | nM | PubChem BioAssay data set |
| NPT94 | Individual protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
| NPT54 | Individual protein | Nonstructural protein 1 | Influenza A virus | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
| NPT538 | Individual protein | Niemann-Pick C1 protein | Homo sapiens | Potency | = | 2511.9 | nM | PubChem BioAssay data set |
| NPT61 | Individual protein | Beta-glucocerebrosidase | Homo sapiens | Potency | n.a. | 22387.2 | nM | PubChem BioAssay data set |
| NPT61 | Individual protein | Beta-glucocerebrosidase | Homo sapiens | Potency | n.a. | 5623.4 | nM | PubChem BioAssay data set |
| NPT584 | Individual protein | NACHT, LRR and PYD domains-containing protein 3 | Homo sapiens | IC50 | = | 31000.0 | nM | PubChem BioAssay data set |
| NPT584 | Individual protein | NACHT, LRR and PYD domains-containing protein 3 | Homo sapiens | IC50 | = | 5400.0 | nM | PubChem BioAssay data set |
| NPT7 | Individual protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | n.a. | 12589.3 | nM | PubChem BioAssay data set |
| NPT484 | Individual protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | n.a. | 6012.0 | nM | PubChem BioAssay data set |
| NPT7 | Individual protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | n.a. | 28183.8 | nM | PubChem BioAssay data set |
| NPT444 | Individual protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | n.a. | 79432.8 | nM | PubChem BioAssay data set |
| NPT588 | Individual protein | Tankyrase-1 | Homo sapiens | IC50 | = | 70.79 | nM | PMID[24116873] |
| NPT588 | Individual protein | Tankyrase-1 | Homo sapiens | IC50 | = | 71.0 | nM | PMID[24116873] |
| NPT73 | Individual protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 201.12 | % | PMID[23571415] |
| NPT20556 | Single protein | Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | 98.35 | % | DOI[10.6019/CHEMBL4495564] |
| NPT93 | Individual protein | Survival motor neuron protein | Homo sapiens | Potency | = | 10000.0 | nM | PubChem BioAssay data set |
| NPT51 | Individual protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
| NPT46 | Individual protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | = | 158489.3 | nM | PubChem BioAssay data set |
| NPT51 | Individual protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 2818.4 | nM | PubChem BioAssay data set |
| NPT583 | Individual protein | Inositol monophosphatase 1 | Rattus norvegicus | Potency | = | 28183.8 | nM | PubChem BioAssay data set |
| NPT535 | Individual protein | Parathyroid hormone receptor | Homo sapiens | Potency | n.a. | 39810.7 | nM | PubChem BioAssay data set |
| NPT581 | Individual protein | Cyclooxygenase-2 | Mus musculus | Inhibition | = | 38.9 | % | PMID[14980657] |
| NPT536 | Nucleic acid | microRNA 21 | Homo sapiens | Potency | = | 5847.9 | nM | PubChem BioAssay data set |
| NPT539 | Individual protein | Cellular tumor antigen p53 | Homo sapiens | Potency | = | 10000.0 | nM | PubChem BioAssay data set |
| NPT539 | Individual protein | Cellular tumor antigen p53 | Homo sapiens | Potency | = | 25118.9 | nM | PubChem BioAssay data set |
| NPT443 | Individual protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | n.a. | 12589.3 | nM | PubChem BioAssay data set |
| NPT443 | Individual protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | n.a. | 8912.5 | nM | PubChem BioAssay data set |
| NPT64 | Individual protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | n.a. | 20587.8 | nM | PubChem BioAssay data set |
| NPT64 | Individual protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | n.a. | 11577.4 | nM | PubChem BioAssay data set |
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT384 | Cell line | TK-10 | Homo sapiens | Activity | = | 82.0 | % | PMID[17383189] |
| NPT83 | Cell line | MCF7 | Homo sapiens | Activity | = | 100.0 | % | PMID[17383189] |
| NPT139 | Cell line | HT-29 | Homo sapiens | Activity | = | 100.0 | % | PMID[17383189] |
| NPT65 | Cell line | HepG2 | Homo sapiens | Potency | n.a. | 2818.4 | nM | PubChem BioAssay data set |
| NPT71 | Cell line | HEK293 | Homo sapiens | IC50 | > | 67535.0 | nM | PubChem BioAssay data set |
| NPT65 | Cell line | HepG2 | Homo sapiens | GI | < | 50.0 | % | DOI[10.1007/s00044-012-0423-1] |
| NPT112 | Cell line | MOLT-4 | Homo sapiens | GI50 | = | 99200.0 | nM | DOI[10.1007/s00044-012-0423-1] |
| NPT83 | Cell line | MCF7 | Homo sapiens | GI50 | = | 61800.0 | nM | DOI[10.1007/s00044-012-0423-1] |
| NPT113 | Cell line | RAW264.7 | Mus musculus | Activity | = | 111.45 | % | PMID[28408221] |
| NPT113 | Cell line | RAW264.7 | Mus musculus | Inhibition | = | 8.76 | % | PMID[28408221] |
| NPT616 | Cell line | MDCK | Canis lupus familiaris | CC50 | = | 191800.0 | nM | PMID[31744778] |
| NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 14715.7 | nM | PubChem BioAssay data set |
| NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 2332.3 | nM | PubChem BioAssay data set |
| NPT587 | Tissue | Liver microsome | Rattus norvegicus | IC50 | = | 60.0 | ug.mL-1 | DOI[10.1007/s00044-012-0423-1] |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | -0.08 | % | DOI[10.6019/CHEMBL4495565] |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 20000.0 | nM | DOI[10.6019/CHEMBL4651402] |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 19952.62 | nM | DOI[10.6019/CHEMBL4651402] |
| NPT28438 | Unchecked | Unchecked | n.a. | log(ratio) | = | 0.13 | n.a. | PMID[35576701] |
| NPT20529 | Non-molecular | NON-PROTEIN TARGET | n.a. | deltaA | = | 0.24 | n.a. | PMID[20565070] |
| NPT586 | Organism | Giardia | Giardia | Potency | n.a. | 23053.0 | nM | PubChem BioAssay data set |
| NPT29337 | Protein family | Cytochrome P450 | Homo sapiens | Inhibition | = | 27.0 | % | PMID[35576701] |
| NPT29337 | Protein family | Cytochrome P450 | Homo sapiens | Inhibition | = | 20.0 | % | PMID[35576701] |
| NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 6.3 | ug.mL-1 | PMID[11170636] |
| NPT2 | Others | Unspecified | n.a. | Activity | = | 0.0 | n.a. | PMID[8882428] |
| NPT2 | Others | Unspecified | n.a. | Ratio IC50 | > | 3.6 | n.a. | PMID[20045650] |
| NPT2 | Others | Unspecified | n.a. | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | Potency | = | 11.2 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 1258.9 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 12589.3 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 22387.2 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 17782.8 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 1778.3 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 3162.3 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 7079.5 | nM | PubChem BioAssay data set |
| NPT742 | Organism | Influenza A virus | Influenza A virus | EC50 | = | 9.36 | nM | PMID[31744778] |
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Protection | = | 21.0 | % | PMID[8523407] |
Experimental ADME
| Experiment Model | Experiment Tissue | ADME Type | ADME Relation | ADME Value | ADME Unit | Reference |
|---|
Experimental Toxicity
| Experiment Model | Experiment Organism | Toxicity Type | Toxicity Relation | Toxicity Value | Toxicity Unit | Reference |
|---|
Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria
| Hepatotoxicity | Carcinogenicity | Mutagenicity | Cardiotoxicity | Respiratory Toxicity | Eye Irritation | Endocrine Disruption |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
☉ ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
☉ TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]
  Chemically structural similarityTop-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)
Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.
●  The left chart: Distribution of similarity level between NPC2771 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).
| Similarity Score | Similarity Level | Natural Product ID |
|---|---|---|
| 0.7755 | Intermediate Similarity | NPC77955 |
| 0.7755 | Intermediate Similarity | NPC608264 |
| 0.75 | Intermediate Similarity | NPC483772 |
| 0.7292 | Intermediate Similarity | NPC604293 |
| 0.7143 | Intermediate Similarity | NPC603094 |
| 0.7111 | Intermediate Similarity | NPC32298 |
| 0.6863 | Remote Similarity | NPC608669 |
| 0.6731 | Remote Similarity | NPC125887 |
| 0.6731 | Remote Similarity | NPC483774 |
| 0.6604 | Remote Similarity | NPC266597 |
| 0.6604 | Remote Similarity | NPC604085 |
| 0.66 | Remote Similarity | NPC607644 |
| 0.6481 | Remote Similarity | NPC480173 |
| 0.6471 | Remote Similarity | NPC284424 |
| 0.64 | Remote Similarity | NPC22783 |
| 0.64 | Remote Similarity | NPC196034 |
| 0.6296 | Remote Similarity | NPC605146 |
| 0.5965 | Remote Similarity | NPC605336 |
| 0.5926 | Remote Similarity | NPC599976 |
| 0.5849 | Remote Similarity | NPC101294 |
| 0.5818 | Remote Similarity | NPC113089 |
| 0.5769 | Remote Similarity | NPC41721 |
| 0.5741 | Remote Similarity | NPC14958 |
| 0.5714 | Remote Similarity | NPC250266 |
| 0.569 | Remote Similarity | NPC606525 |
| 0.5536 | Remote Similarity | NPC156222 |
| 0.5536 | Remote Similarity | NPC29353 |
| 0.5439 | Remote Similarity | NPC184136 |
| 0.5439 | Remote Similarity | NPC231772 |
| 0.5439 | Remote Similarity | NPC57030 |
| 0.5439 | Remote Similarity | NPC22519 |
| 0.5439 | Remote Similarity | NPC145379 |
| 0.537 | Remote Similarity | NPC40818 |
| 0.537 | Remote Similarity | NPC193805 |
| 0.5345 | Remote Similarity | NPC603662 |
| 0.5273 | Remote Similarity | NPC602026 |
| 0.5179 | Remote Similarity | NPC333230 |
| 0.5179 | Remote Similarity | NPC129680 |
| 0.5167 | Remote Similarity | NPC604422 |
| 0.5167 | Remote Similarity | NPC607642 |
| 0.5094 | Remote Similarity | NPC602460 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC2771 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).
| Similarity Score | Similarity Level | Drug ID | Developmental Stage |
|---|---|---|---|
| NPD |
  Bioactivity similaritySimilarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.
